baldų studija Plienmedis - Company finances
|
EUR
|
2019
From: 2019-08-21
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 1,065 | 5,016 | 28,668 | 47,292 | 148,338 | 94,757 | 130,068 |
| Profit before tax | - | 526 | 5,909 | 3,200 | 17,050 | -2,311 | 8,053 |
| Net profit | 347 | 500 | 5,614 | 3,040 | 15,997 | -2,311 | 8,053 |
| Equity | 518 | 917 | 4,531 | 7,572 | 23,569 | 21,258 | 21,311 |
| Liabilities | 17 | - | - | 3,829 | 23,032 | 17,387 | 24,612 |
| Non-current assets | 12,689 | 9,486 | 13,828 | 10,025 | 23,824 | 20,812 | 26,074 |
| Current assets | 515 | 1,380 | 2,967 | 4,436 | 24,933 | 19,084 | 21,100 |
| Total assets | 13,204 | 10,866 | 16,795 | 14,461 | 48,757 | 39,896 | 47,174 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | - | 8,101 | 5,577 |
| Social insurance contributions | - | - | - | - | - | - | 692 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +371.0% | +471.5% | +65.0% | +213.7% | -36.1% | +37.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.6% | 4.6% | 33.4% | 21.0% | 32.8% | -5.8% | 17.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 67.0% | 54.5% | 123.9% | 40.1% | 67.9% | -10.9% | 37.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 32.6% | 10.0% | 19.6% | 6.4% | 10.8% | -2.4% | 6.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 10.5% | 20.6% | 6.8% | 11.5% | -2.4% | 6.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | - | - | 0.5 | 1.0 | 0.8 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 20,809 | 57,422 | 47,379 | 47,297 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
baldų studija Plienmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-05 | 2026-05-10 | 183.80 |
| 2025-08-01 | 2025-08-03 | 0.07 |
| 2025-07-16 | 2025-07-16 | 0.78 |
| 2025-05-04 | 2025-05-11 | 231.32 |
| 2024-05-15 | 2024-05-20 | 393.65 |
baldų studija Plienmedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-30 | 2026-07-07 | 45.31 |
| 2026-06-28 | 2026-06-29 | 46.18 |
| 2026-05-01 | 2026-05-03 | 412.33 |
| 2026-04-30 | 2026-04-30 | 412.0 |
| 2026-01-14 | 2026-01-19 | 0.58 |
| 2026-01-01 | 2026-01-05 | 2229.16 |
| 2025-12-01 | 2025-12-29 | 0.02 |
| 2025-09-30 | 2025-09-30 | 1.12 |
| 2025-09-28 | 2025-09-29 | 1065.42 |
| 2025-08-13 | 2025-08-15 | 136.18 |
| 2025-07-29 | 2025-07-31 | 1.18 |
| 2025-07-28 | 2025-07-28 | 862.18 |
| 2025-07-27 | 2025-07-27 | 1.18 |
| 2025-07-26 | 2025-07-26 | 0.3 |
| 2025-07-17 | 2025-07-23 | 62.21 |
| 2025-05-01 | 2025-05-13 | 0.72 |
| 2025-04-28 | 2025-04-28 | 878.32 |
| 2025-01-16 | 2025-01-25 | 0.4 |
| 2025-01-14 | 2025-01-15 | 70.8 |
| 2025-01-01 | 2025-01-01 | 1.02 |
| 2024-12-30 | 2024-12-30 | 1863.56 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Plienmedis, MB (code 305230093) is a Small partnership engaged in furniture manufacture. In 2025, the company generated revenue of €130.1K, up 37.3% year on year from €94.8K in 2024, though still below the €148.3K achieved in 2023. Net profit in 2025 reached €8.1K, compared with a net loss of €2.3K in 2024 and profit of €16.0K in 2023, showing a return to profitability after a weaker prior year. The 2025 profit margin was 6.2%, improving from -2.4% in 2024 but remaining below the 10.8% recorded in 2023. At the end of 2025, total assets stood at €47.2K, equity at €21.3K, and liabilities at €24.6K. Equity was unchanged from 2024, while liabilities increased. Long-term assets were €26.1K and short-term assets €21.1K. Key ratios indicate efficient asset use, with asset turnover of 2.76x, ROE of 37.8%, and ROA of 17.1%. Revenue per employee was €65.0K, supporting a moderate productivity profile.